Dear editor,

My name is Marie-Lou Lizotte-Buisson. I'm a francophone who studying radio-oncology at college ahuntsic in Montreal.

For my English class, I have to write a critic on an article of my choice. The title of the news is Accuray receives shonin approval to market Cyberknife G4 Robotic Radiosurgery System.

I am very encouraged to see how the technology moves forwards to help patients and it's very beautiful to see how this technology extends worldwide. It's very well that more time passes, more the Cyberknife can treat more and more tumors. I agree that this new Cyberknife can be on Japan because on this country there are a lot of cancers who develop and there are so much people. So they very need it. Then, this hardware reduces de time of treatments of 50% and it's very advantageous for hospital that have oncology department. More patients can be treating on a day and it can congestion the waiting lists. I am impatient to see this technology enter in Canada and I hopeful that it will be performing and help us to treat more cancer types and reduce invasive treatment.